Skip to main content

Table 1 Baseline characteristics of the patients

From: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia

  Control group
(n = 150)
Intervention group
(n = 162)
p value
Age, average (SD) 66.27 (17.9) 64.72 (18.7) 0.46
Sex, n (%)    0.86
 Male 95 (63.3) 101 (62.3)  
 Female 55 (36.7) 61 (37.7)  
Comorbidities, n (%)
 Liver disease 4 (2.7) 4 (2.5) 1.00
 Heart disease 38 (25.3) 39 (24.1) 0.80
 Congestive heart failure 14 (9.3) 12 (7.4) 0.54
 Cerebrovascular disease 16 (10.7) 9 (5.6) 0.10
 Kidney disease 12 (8.0) 12 (7.4) 0.84
 COPD 21 (14) 27 (16.7) 0.51
 Diabetes mellitus 25 (16.7) 21 (12.0) 0.36
Charlson Index, median (IQR) 1 (0–2) 1 (0–2) 0.35
Charlson Index, categorized, n (%)    0.40
 0 61 (40.7) 70 (43.2)  
 1 37 (24.7) 47 (29.0)  
  > 1 52 (34.7) 45 (27.8)  
Categorized PSI, n (%)    0.51
 I-III 89 (59.3) 102 (63)  
 IV-V 61 (40.7) 60 (37.0)  
PSI, average (SD) 83.7 (33.7) 81.8 (33.8) 0.63
  1. Data are presented as average (SD), median (IQR) or n (%)
  2. SD Standard Deviation, IQR Interquartile range